0.76
2.06%
-0.016
Finanzdaten der Quoin Pharmaceuticals Ltd ADR-Aktie (QNRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
1.38%
1.3853
|
1.3665 | 1.635 | 1.6838 |
Nonoperating Income/Loss |
15.49%
0.1678
|
0.1985 | 0.1531 | 0.1725 |
Income/Loss From Continuing Operations Before Tax |
6.39%
-2.0499
|
-1.9267 | -2.1069 | -2.6031 |
Income/Loss From Continuing Operations After Tax |
6.39%
-2.0499
|
-1.9267 | -2.1069 | -2.6031 |
Net Income/Loss
|
6.39%
-2.0499
|
-1.9267 | -2.1069 | -2.6031 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
Kapitalisierung:
|
Volumen (24h):